Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

Forbes John F., Sestak Ivana, Howell Anthony, Bonanni Bernardo, Bundred Nigel, Levy Christelle, Minkwitz Gunter von, Eiermann Wolfgang, Neven Patrick, Stierer Michael, Holcombe Chris, Coleman Robert E., Jones Louise, Ellis Ian, Cuzick Jack, Kahán Zsuzsanna: Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
LANCET, (387) 10021. pp. 866-873. ISSN 0140-6736 (2016)

[img]
Preview
Text
1_s2.0_S0140673615011290_main_u.pdf - Published Version

Download (409kB) | Preview
Item Type: Article
Journal or Publication Title: LANCET
Date: 2016
Volume: 387
Number: 10021
Page Range: pp. 866-873
ISSN: 0140-6736
Publisher: The Lancet Publishing Group
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
SWORD language: Angol
Identification Number: 3257984
DOI id: https://doi.org/10.1016/S0140-6736(15)01129-0
Date Deposited: 2017. Aug. 30. 10:58
Last Modified: 2017. Aug. 30. 10:58
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11864

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year